A new study by University of Kentucky researchers has identified a novel molecule named Arylquin 1 as a potent inducer of Par-4, a protein that acts as a tumor suppressor, killing cancer cells while leaving normal cells unharmed.

The project will focus on policies related to the built environment (such as sidewalks), overall community design, and shared use of schools (after school hours) to increase access to safe space for physical activity.

Researchers at UK are using magnetic resonance imaging (MRI) technology to better understand the cause of heart failure in patients who received corrective surgery as infants, with the goal of eventually developing new therapies to reduce mortality.

Kentucky is ranked third in the U.S. for incidence of depression, with 23.5 percent of adults experiencing depression at some point during their lives, compared to 18 percent nationally.

Dr. Arthur Nitz and Dr. Babak Bazrgari are working towards a better understanding of the back’s mechanical environment in order to generate more accurate knowledge of the specific, biomechanical causes of back pain.

With the funding and support from the CCTS and the National Institutes of Health, Noehren studies how muscle and physical function are affected by knee injuries--a significant source of disability in the United States--and how best to intervene and treat such injuries.

As an otolaryngologist at the University of Kentucky, Dr. Matthew Bush focuses on rural health disparities of pediatric hearing loss, particularly in Appalachia.

A multidisciplinary group of University of Kentucky researchers is working to find if exercise can improve the brain.

Established in 2006, the Pilot Program provides funding and multidisciplinary research support for preliminary and proof-of-concept studies in translational science.

Mandy Jones has received a highly-competitive CCTS pilot award to analyze and transform the culture of medical error disclosure in health systems utilizing interprofessional teams.